These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis. Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656 [TBL] [Abstract][Full Text] [Related]
8. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900 [TBL] [Abstract][Full Text] [Related]
9. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity. Vrouenraets SM; Fux CA; Wit FW; Garcia EF; Furrer H; Brinkman K; Hoek FJ; Abeling NG; Krediet RT; Reiss P; AIDS; 2011 Nov; 25(17):2149-55. PubMed ID: 21857491 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023 [TBL] [Abstract][Full Text] [Related]
16. Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients. Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K Nephrol Dial Transplant; 2011 Dec; 26(12):3923-9. PubMed ID: 21427068 [TBL] [Abstract][Full Text] [Related]
17. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial. Franz S; Regeniter A; Hopfer H; Mihatsch M; Dickenmann M Am J Kidney Dis; 2010 Feb; 55(2):335-43. PubMed ID: 19926370 [TBL] [Abstract][Full Text] [Related]
18. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F; Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870 [TBL] [Abstract][Full Text] [Related]
19. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City. Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063 [TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]